<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2001-01-11" modified="2020-10-07" version="195">
<accession>O75899</accession>
<accession>O75974</accession>
<accession>O75975</accession>
<accession>Q5VXZ2</accession>
<accession>Q8WX04</accession>
<accession>Q9P1R2</accession>
<accession>Q9UNR1</accession>
<accession>Q9UNS9</accession>
<name>GABR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Gamma-aminobutyric acid type B receptor subunit 2</fullName>
<shortName>GABA-B receptor 2</shortName>
<shortName>GABA-B-R2</shortName>
<shortName>GABA-BR2</shortName>
<shortName>GABABR2</shortName>
<shortName>Gb2</shortName>
</recommendedName>
<alternativeName>
<fullName>G-protein coupled receptor 51</fullName>
</alternativeName>
<alternativeName>
<fullName>HG20</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">GABBR2</name>
<name type="synonym">GPR51</name>
<name type="synonym">GPRC3B</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1998" name="Nature" volume="396" first="679" last="682">
<title>Heterodimerization is required for the formation of a functional GABA(B) receptor.</title>
<authorList>
<person name="White J.H."/>
<person name="Wise A."/>
<person name="Main M.J."/>
<person name="Green A."/>
<person name="Fraser N.J."/>
<person name="Disney G.H."/>
<person name="Barnes A.A."/>
<person name="Emson P."/>
<person name="Foord S.M."/>
<person name="Marshall F.H."/>
</authorList>
<dbReference type="PubMed" id="9872316"/>
<dbReference type="DOI" id="10.1038/25354"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH GABBR1</scope>
<scope>SUBCELLULAR LOCATION</scope>
<source>
<tissue evidence="30">Cerebellum</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Genomics" volume="56" first="288" last="295">
<title>Cloning of a novel G-protein-coupled receptor GPR 51 resembling GABAB receptors expressed predominantly in nervous tissues and mapped proximal to the hereditary sensory neuropathy type 1 locus on chromosome 9.</title>
<authorList>
<person name="Ng G.Y.K."/>
<person name="McDonald T."/>
<person name="Bonnert T."/>
<person name="Rigby M."/>
<person name="Heavens R."/>
<person name="Whiting P."/>
<person name="Chateauneuf A."/>
<person name="Coulombe N."/>
<person name="Kargman S."/>
<person name="Caskey T."/>
<person name="Evans J.F."/>
<person name="O'Neill G.P."/>
<person name="Liu Q."/>
</authorList>
<dbReference type="PubMed" id="10087195"/>
<dbReference type="DOI" id="10.1006/geno.1998.5706"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue evidence="26">Fetal brain</tissue>
</source>
</reference>
<reference key="3">
<citation type="journal article" date="1999" name="Mol. Cell. Neurosci." volume="13" first="180" last="191">
<title>Molecular identification of the human GABABR2: cell surface expression and coupling to adenylyl cyclase in the absence of GABABR1.</title>
<authorList>
<person name="Martin S.C."/>
<person name="Russek S.J."/>
<person name="Farb D.H."/>
</authorList>
<dbReference type="PubMed" id="10328880"/>
<dbReference type="DOI" id="10.1006/mcne.1999.0741"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>VARIANTS PHE-628 AND ALA-869</scope>
<source>
<tissue evidence="27">Brain</tissue>
</source>
</reference>
<reference key="4">
<citation type="journal article" date="2000" name="Brain Res." volume="860" first="41" last="52">
<title>Distribution of the GABA(B) receptor subunit gb2 in rat CNS.</title>
<authorList>
<person name="Clark J.A."/>
<person name="Mezey E."/>
<person name="Lam A.S."/>
<person name="Bonner T.I."/>
</authorList>
<dbReference type="PubMed" id="10727622"/>
<dbReference type="DOI" id="10.1016/s0006-8993(00)01958-2"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue evidence="28">Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="submission" date="1998-11" db="EMBL/GenBank/DDBJ databases">
<title>Cloning and characterization of a novel human GABA-B receptor subtype with high affinity for GABA and low affinity for baclofen.</title>
<authorList>
<person name="Liu M."/>
<person name="Parker R."/>
<person name="McCrea K."/>
<person name="Watson J."/>
<person name="Baker E."/>
<person name="Sutherland G."/>
<person name="Herzog H."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
</reference>
<reference key="6">
<citation type="submission" date="1999-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Borowsky B."/>
<person name="Laz T."/>
<person name="Gerald C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<source>
<tissue evidence="31">Hippocampus</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nature" volume="429" first="369" last="374">
<title>DNA sequence and analysis of human chromosome 9.</title>
<authorList>
<person name="Humphray S.J."/>
<person name="Oliver K."/>
<person name="Hunt A.R."/>
<person name="Plumb R.W."/>
<person name="Loveland J.E."/>
<person name="Howe K.L."/>
<person name="Andrews T.D."/>
<person name="Searle S."/>
<person name="Hunt S.E."/>
<person name="Scott C.E."/>
<person name="Jones M.C."/>
<person name="Ainscough R."/>
<person name="Almeida J.P."/>
<person name="Ambrose K.D."/>
<person name="Ashwell R.I.S."/>
<person name="Babbage A.K."/>
<person name="Babbage S."/>
<person name="Bagguley C.L."/>
<person name="Bailey J."/>
<person name="Banerjee R."/>
<person name="Barker D.J."/>
<person name="Barlow K.F."/>
<person name="Bates K."/>
<person name="Beasley H."/>
<person name="Beasley O."/>
<person name="Bird C.P."/>
<person name="Bray-Allen S."/>
<person name="Brown A.J."/>
<person name="Brown J.Y."/>
<person name="Burford D."/>
<person name="Burrill W."/>
<person name="Burton J."/>
<person name="Carder C."/>
<person name="Carter N.P."/>
<person name="Chapman J.C."/>
<person name="Chen Y."/>
<person name="Clarke G."/>
<person name="Clark S.Y."/>
<person name="Clee C.M."/>
<person name="Clegg S."/>
<person name="Collier R.E."/>
<person name="Corby N."/>
<person name="Crosier M."/>
<person name="Cummings A.T."/>
<person name="Davies J."/>
<person name="Dhami P."/>
<person name="Dunn M."/>
<person name="Dutta I."/>
<person name="Dyer L.W."/>
<person name="Earthrowl M.E."/>
<person name="Faulkner L."/>
<person name="Fleming C.J."/>
<person name="Frankish A."/>
<person name="Frankland J.A."/>
<person name="French L."/>
<person name="Fricker D.G."/>
<person name="Garner P."/>
<person name="Garnett J."/>
<person name="Ghori J."/>
<person name="Gilbert J.G.R."/>
<person name="Glison C."/>
<person name="Grafham D.V."/>
<person name="Gribble S."/>
<person name="Griffiths C."/>
<person name="Griffiths-Jones S."/>
<person name="Grocock R."/>
<person name="Guy J."/>
<person name="Hall R.E."/>
<person name="Hammond S."/>
<person name="Harley J.L."/>
<person name="Harrison E.S.I."/>
<person name="Hart E.A."/>
<person name="Heath P.D."/>
<person name="Henderson C.D."/>
<person name="Hopkins B.L."/>
<person name="Howard P.J."/>
<person name="Howden P.J."/>
<person name="Huckle E."/>
<person name="Johnson C."/>
<person name="Johnson D."/>
<person name="Joy A.A."/>
<person name="Kay M."/>
<person name="Keenan S."/>
<person name="Kershaw J.K."/>
<person name="Kimberley A.M."/>
<person name="King A."/>
<person name="Knights A."/>
<person name="Laird G.K."/>
<person name="Langford C."/>
<person name="Lawlor S."/>
<person name="Leongamornlert D.A."/>
<person name="Leversha M."/>
<person name="Lloyd C."/>
<person name="Lloyd D.M."/>
<person name="Lovell J."/>
<person name="Martin S."/>
<person name="Mashreghi-Mohammadi M."/>
<person name="Matthews L."/>
<person name="McLaren S."/>
<person name="McLay K.E."/>
<person name="McMurray A."/>
<person name="Milne S."/>
<person name="Nickerson T."/>
<person name="Nisbett J."/>
<person name="Nordsiek G."/>
<person name="Pearce A.V."/>
<person name="Peck A.I."/>
<person name="Porter K.M."/>
<person name="Pandian R."/>
<person name="Pelan S."/>
<person name="Phillimore B."/>
<person name="Povey S."/>
<person name="Ramsey Y."/>
<person name="Rand V."/>
<person name="Scharfe M."/>
<person name="Sehra H.K."/>
<person name="Shownkeen R."/>
<person name="Sims S.K."/>
<person name="Skuce C.D."/>
<person name="Smith M."/>
<person name="Steward C.A."/>
<person name="Swarbreck D."/>
<person name="Sycamore N."/>
<person name="Tester J."/>
<person name="Thorpe A."/>
<person name="Tracey A."/>
<person name="Tromans A."/>
<person name="Thomas D.W."/>
<person name="Wall M."/>
<person name="Wallis J.M."/>
<person name="West A.P."/>
<person name="Whitehead S.L."/>
<person name="Willey D.L."/>
<person name="Williams S.A."/>
<person name="Wilming L."/>
<person name="Wray P.W."/>
<person name="Young L."/>
<person name="Ashurst J.L."/>
<person name="Coulson A."/>
<person name="Blocker H."/>
<person name="Durbin R.M."/>
<person name="Sulston J.E."/>
<person name="Hubbard T."/>
<person name="Jackson M.J."/>
<person name="Bentley D.R."/>
<person name="Beck S."/>
<person name="Rogers J."/>
<person name="Dunham I."/>
</authorList>
<dbReference type="PubMed" id="15164053"/>
<dbReference type="DOI" id="10.1038/nature02465"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 14-941</scope>
<source>
<tissue evidence="29">Hippocampus</tissue>
</source>
</reference>
<reference key="9">
<citation type="journal article" date="1999" name="J. Biol. Chem." volume="274" first="7607" last="7610">
<title>Identification of a GABAB receptor subunit, gb2, required for functional GABAB receptor activity.</title>
<authorList>
<person name="Ng G.Y.K."/>
<person name="Clark J."/>
<person name="Coulombe N."/>
<person name="Ethier N."/>
<person name="Hebert T.E."/>
<person name="Sullivan R."/>
<person name="Kargman S."/>
<person name="Chateauneuf A."/>
<person name="Tsukamoto N."/>
<person name="McDonald T."/>
<person name="Whiting P."/>
<person name="Mezey E."/>
<person name="Johnson M.P."/>
<person name="Liu Q."/>
<person name="Kolakowski L.F. Jr."/>
<person name="Evans J.F."/>
<person name="Bonner T.I."/>
<person name="O'Neill G.P."/>
</authorList>
<dbReference type="PubMed" id="10075644"/>
<dbReference type="DOI" id="10.1074/jbc.274.12.7607"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="1999" name="Science" volume="283" first="74" last="77">
<title>Role of heteromer formation in GABAB receptor function.</title>
<authorList>
<person name="Kuner R."/>
<person name="Koehr G."/>
<person name="Gruenewald S."/>
<person name="Eisenhardt G."/>
<person name="Bach A."/>
<person name="Kornau H.-C."/>
</authorList>
<dbReference type="PubMed" id="9872744"/>
<dbReference type="DOI" id="10.1126/science.283.5398.74"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GABBR1</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>DOMAIN</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2000" name="J. Biol. Chem." volume="275" first="32174" last="32181">
<title>Characterization of gamma-aminobutyric acid receptor GABAB(1e), a GABAB(1) splice variant encoding a truncated receptor.</title>
<authorList>
<person name="Schwarz D.A."/>
<person name="Barry G."/>
<person name="Eliasof S.D."/>
<person name="Petroski R.E."/>
<person name="Conlon P.J."/>
<person name="Maki R.A."/>
</authorList>
<dbReference type="PubMed" id="10906333"/>
<dbReference type="DOI" id="10.1074/jbc.m005333200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GABBR1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2000" name="J. Pharmacol. Exp. Ther." volume="293" first="460" last="467">
<title>Coexpression of full-length gamma-aminobutyric acid(B) (GABA(B)) receptors with truncated receptors and metabotropic glutamate receptor 4 supports the GABA(B) heterodimer as the functional receptor.</title>
<authorList>
<person name="Sullivan R."/>
<person name="Chateauneuf A."/>
<person name="Coulombe N."/>
<person name="Kolakowski L.F. Jr."/>
<person name="Johnson M.P."/>
<person name="Hebert T.E."/>
<person name="Ethier N."/>
<person name="Belley M."/>
<person name="Metters K."/>
<person name="Abramovitz M."/>
<person name="O'Neill G.P."/>
<person name="Ng G.Y.K."/>
</authorList>
<dbReference type="PubMed" id="10773016"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GABBR1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2016" name="J. Med. Genet." volume="53" first="190" last="199">
<title>Identification of novel genetic causes of Rett syndrome-like phenotypes.</title>
<authorList>
<person name="Lopes F."/>
<person name="Barbosa M."/>
<person name="Ameur A."/>
<person name="Soares G."/>
<person name="de Sa J."/>
<person name="Dias A.I."/>
<person name="Oliveira G."/>
<person name="Cabral P."/>
<person name="Temudo T."/>
<person name="Calado E."/>
<person name="Cruz I.F."/>
<person name="Vieira J.P."/>
<person name="Oliveira R."/>
<person name="Esteves S."/>
<person name="Sauer S."/>
<person name="Jonasson I."/>
<person name="Syvaenen A.C."/>
<person name="Gyllensten U."/>
<person name="Pinto D."/>
<person name="Maciel P."/>
</authorList>
<dbReference type="PubMed" id="26740508"/>
<dbReference type="DOI" id="10.1136/jmedgenet-2015-103568"/>
</citation>
<scope>VARIANT NDPLHS THR-567</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="Biochem. J." volume="388" first="47" last="55">
<title>Subcellular distribution of GABA(B) receptor homo- and hetero-dimers.</title>
<authorList>
<person name="Villemure J.F."/>
<person name="Adam L."/>
<person name="Bevan N.J."/>
<person name="Gearing K."/>
<person name="Chenier S."/>
<person name="Bouvier M."/>
</authorList>
<dbReference type="PubMed" id="15617512"/>
<dbReference type="DOI" id="10.1042/bj20041435"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GABBR1</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2008" name="J. Biol. Chem." volume="283" first="4665" last="4673">
<title>Direct detection of the interaction between recombinant soluble extracellular regions in the heterodimeric metabotropic gamma-aminobutyric acid receptor.</title>
<authorList>
<person name="Nomura R."/>
<person name="Suzuki Y."/>
<person name="Kakizuka A."/>
<person name="Jingami H."/>
</authorList>
<dbReference type="PubMed" id="18165688"/>
<dbReference type="DOI" id="10.1074/jbc.m705202200"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>INTERACTION WITH GABBR1</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2012" name="Nat. Neurosci." volume="15" first="970" last="978">
<title>Structure and functional interaction of the extracellular domain of human GABA(B) receptor GBR2.</title>
<authorList>
<person name="Geng Y."/>
<person name="Xiong D."/>
<person name="Mosyak L."/>
<person name="Malito D.L."/>
<person name="Kniazeff J."/>
<person name="Chen Y."/>
<person name="Burmakina S."/>
<person name="Quick M."/>
<person name="Bush M."/>
<person name="Javitch J.A."/>
<person name="Pin J.P."/>
<person name="Fan Q.R."/>
</authorList>
<dbReference type="PubMed" id="22660477"/>
<dbReference type="DOI" id="10.1038/nn.3133"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.38 ANGSTROMS) OF 42-466</scope>
<scope>PARTIAL PROTEIN SEQUENCE</scope>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH GABBR1</scope>
<scope>MUTAGENESIS OF TYR-118</scope>
<scope>GLYCOSYLATION AT ASN-90; ASN-389; ASN-404 AND ASN-453</scope>
<scope>DISULFIDE BONDS</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2013" name="Nature" volume="504" first="254" last="259">
<title>Structural mechanism of ligand activation in human GABA(B) receptor.</title>
<authorList>
<person name="Geng Y."/>
<person name="Bush M."/>
<person name="Mosyak L."/>
<person name="Wang F."/>
<person name="Fan Q.R."/>
</authorList>
<dbReference type="PubMed" id="24305054"/>
<dbReference type="DOI" id="10.1038/nature12725"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 42-466 IN COMPLEXES WITH GABBR1; AGONISTS AND ANTAGONISTS</scope>
<scope>FUNCTION</scope>
<scope>SUBUNIT</scope>
<scope>GLYCOSYLATION AT ASN-404</scope>
<scope>DISULFIDE BOND</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="101" first="664" last="685">
<title>High rate of recurrent de novo mutations in developmental and epileptic encephalopathies.</title>
<authorList>
<consortium name="Deciphering Developmental Disorders Study"/>
<person name="Hamdan F.F."/>
<person name="Myers C.T."/>
<person name="Cossette P."/>
<person name="Lemay P."/>
<person name="Spiegelman D."/>
<person name="Laporte A.D."/>
<person name="Nassif C."/>
<person name="Diallo O."/>
<person name="Monlong J."/>
<person name="Cadieux-Dion M."/>
<person name="Dobrzeniecka S."/>
<person name="Meloche C."/>
<person name="Retterer K."/>
<person name="Cho M.T."/>
<person name="Rosenfeld J.A."/>
<person name="Bi W."/>
<person name="Massicotte C."/>
<person name="Miguet M."/>
<person name="Brunga L."/>
<person name="Regan B.M."/>
<person name="Mo K."/>
<person name="Tam C."/>
<person name="Schneider A."/>
<person name="Hollingsworth G."/>
<person name="FitzPatrick D.R."/>
<person name="Donaldson A."/>
<person name="Canham N."/>
<person name="Blair E."/>
<person name="Kerr B."/>
<person name="Fry A.E."/>
<person name="Thomas R.H."/>
<person name="Shelagh J."/>
<person name="Hurst J.A."/>
<person name="Brittain H."/>
<person name="Blyth M."/>
<person name="Lebel R.R."/>
<person name="Gerkes E.H."/>
<person name="Davis-Keppen L."/>
<person name="Stein Q."/>
<person name="Chung W.K."/>
<person name="Dorison S.J."/>
<person name="Benke P.J."/>
<person name="Fassi E."/>
<person name="Corsten-Janssen N."/>
<person name="Kamsteeg E.J."/>
<person name="Mau-Them F.T."/>
<person name="Bruel A.L."/>
<person name="Verloes A."/>
<person name="Ounap K."/>
<person name="Wojcik M.H."/>
<person name="Albert D.V.F."/>
<person name="Venkateswaran S."/>
<person name="Ware T."/>
<person name="Jones D."/>
<person name="Liu Y.C."/>
<person name="Mohammad S.S."/>
<person name="Bizargity P."/>
<person name="Bacino C.A."/>
<person name="Leuzzi V."/>
<person name="Martinelli S."/>
<person name="Dallapiccola B."/>
<person name="Tartaglia M."/>
<person name="Blumkin L."/>
<person name="Wierenga K.J."/>
<person name="Purcarin G."/>
<person name="O'Byrne J.J."/>
<person name="Stockler S."/>
<person name="Lehman A."/>
<person name="Keren B."/>
<person name="Nougues M.C."/>
<person name="Mignot C."/>
<person name="Auvin S."/>
<person name="Nava C."/>
<person name="Hiatt S.M."/>
<person name="Bebin M."/>
<person name="Shao Y."/>
<person name="Scaglia F."/>
<person name="Lalani S.R."/>
<person name="Frye R.E."/>
<person name="Jarjour I.T."/>
<person name="Jacques S."/>
<person name="Boucher R.M."/>
<person name="Riou E."/>
<person name="Srour M."/>
<person name="Carmant L."/>
<person name="Lortie A."/>
<person name="Major P."/>
<person name="Diadori P."/>
<person name="Dubeau F."/>
<person name="D'Anjou G."/>
<person name="Bourque G."/>
<person name="Berkovic S.F."/>
<person name="Sadleir L.G."/>
<person name="Campeau P.M."/>
<person name="Kibar Z."/>
<person name="Lafreniere R.G."/>
<person name="Girard S.L."/>
<person name="Mercimek-Mahmutoglu S."/>
<person name="Boelman C."/>
<person name="Rouleau G.A."/>
<person name="Scheffer I.E."/>
<person name="Mefford H.C."/>
<person name="Andrade D.M."/>
<person name="Rossignol E."/>
<person name="Minassian B.A."/>
<person name="Michaud J.L."/>
</authorList>
<dbReference type="PubMed" id="29100083"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2017.09.008"/>
</citation>
<scope>INVOLVEMENT IN EIEE59</scope>
<scope>VARIANT EIEE59 TRP-693</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2017" name="Ann. Neurol." volume="82" first="466" last="478">
<title>GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy.</title>
<authorList>
<person name="Yoo Y."/>
<person name="Jung J."/>
<person name="Lee Y.N."/>
<person name="Lee Y."/>
<person name="Cho H."/>
<person name="Na E."/>
<person name="Hong J."/>
<person name="Kim E."/>
<person name="Lee J.S."/>
<person name="Lee J.S."/>
<person name="Hong C."/>
<person name="Park S.Y."/>
<person name="Wie J."/>
<person name="Miller K."/>
<person name="Shur N."/>
<person name="Clow C."/>
<person name="Ebel R.S."/>
<person name="DeBrosse S.D."/>
<person name="Henderson L.B."/>
<person name="Willaert R."/>
<person name="Castaldi C."/>
<person name="Tikhonova I."/>
<person name="Bilguevar K."/>
<person name="Mane S."/>
<person name="Kim K.J."/>
<person name="Hwang Y.S."/>
<person name="Lee S.G."/>
<person name="So I."/>
<person name="Lim B.C."/>
<person name="Choi H.J."/>
<person name="Seong J.Y."/>
<person name="Shin Y.B."/>
<person name="Jung H."/>
<person name="Chae J.H."/>
<person name="Choi M."/>
</authorList>
<dbReference type="PubMed" id="28856709"/>
<dbReference type="DOI" id="10.1002/ana.25032"/>
</citation>
<scope>INVOLVEMENT IN NDPLHS</scope>
<scope>INVOLVEMENT IN EIEE59</scope>
<scope>VARIANT NDPLHS THR-567</scope>
<scope>VARIANTS EIEE59 ILE-695 AND ASN-705</scope>
<scope>CHARACTERIZATION OF VARIANT NDPLHS THR-567</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE59 ILE-695 AND ASN-705</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2018" name="Ann. Neurol." volume="83" first="437" last="439">
<title>A novel mutation in the transmembrane 6 domain of GABBR2 leads to a Rett-like phenotype.</title>
<authorList>
<person name="Vuillaume M.L."/>
<person name="Jeanne M."/>
<person name="Xue L."/>
<person name="Blesson S."/>
<person name="Denomme-Pichon A.S."/>
<person name="Alirol S."/>
<person name="Brulard C."/>
<person name="Colin E."/>
<person name="Isidor B."/>
<person name="Gilbert-Dussardier B."/>
<person name="Odent S."/>
<person name="Parent P."/>
<person name="Donnart A."/>
<person name="Redon R."/>
<person name="Bezieau S."/>
<person name="Rondard P."/>
<person name="Laumonnier F."/>
<person name="Toutain A."/>
</authorList>
<dbReference type="PubMed" id="29369404"/>
<dbReference type="DOI" id="10.1002/ana.25155"/>
</citation>
<scope>INVOLVEMENT IN NDPLHS</scope>
<scope>VARIANT NDPLHS THR-707</scope>
<scope>CHARACTERIZATION OF VARIANTS NDPLHS THR-567 AND THR-707</scope>
<scope>CHARACTERIZATION OF VARIANTS EIEE59 ILE-695 AND ASN-705</scope>
</reference>
<comment type="function">
<text evidence="11 13 16 17 18 19 24 25 32">Component of a heterodimeric G-protein coupled receptor for GABA, formed by GABBR1 and GABBR2 (PubMed:9872316, PubMed:9872744, PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054). Within the heterodimeric GABA receptor, only GABBR1 seems to bind agonists, while GABBR2 mediates coupling to G proteins (PubMed:18165688). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase (PubMed:10075644, PubMed:10773016, PubMed:24305054). Signaling inhibits adenylate cyclase, stimulates phospholipase A2, activates potassium channels, inactivates voltage-dependent calcium-channels and modulates inositol phospholipid hydrolysis (PubMed:10075644, PubMed:9872744, PubMed:10906333, PubMed:10773016). Plays a critical role in the fine-tuning of inhibitory synaptic transmission (PubMed:9872744, PubMed:22660477). Pre-synaptic GABA receptor inhibits neurotransmitter release by down-regulating high-voltage activated calcium channels, whereas postsynaptic GABA receptor decreases neuronal excitability by activating a prominent inwardly rectifying potassium (Kir) conductance that underlies the late inhibitory postsynaptic potentials (PubMed:9872316, PubMed:10075644, PubMed:9872744, PubMed:22660477). Not only implicated in synaptic inhibition but also in hippocampal long-term potentiation, slow wave sleep, muscle relaxation and antinociception (Probable).</text>
</comment>
<comment type="subunit">
<text evidence="9 15 16 17 18 19 24 25">Heterodimer of GABBR1 and GABBR2 (PubMed:9872316, PubMed:9872744, PubMed:10906333, PubMed:10773016, PubMed:15617512, PubMed:18165688, PubMed:22660477, PubMed:24305054). Homodimers may form, but are inactive (PubMed:15617512). Interacts (via C-terminus) with ATF4 (via leucine zipper domain) (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-715469">
<id>O75899</id>
</interactant>
<interactant intactId="EBI-724156">
<id>Q9UBS5</id>
<label>GABBR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-715469">
<id>O75899</id>
</interactant>
<interactant intactId="EBI-16084001">
<id>Q9UBS5-2</id>
<label>GABBR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-715469">
<id>O75899</id>
</interactant>
<interactant intactId="EBI-712251">
<id>P46459</id>
<label>NSF</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="13 16 24">Cell membrane</location>
<topology evidence="32">Multi-pass membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="7">Cell junction</location>
<location evidence="7">Synapse</location>
<location evidence="7">Postsynaptic cell membrane</location>
<topology evidence="32">Multi-pass membrane protein</topology>
</subcellularLocation>
<text evidence="16">Coexpression of GABBR1 and GABBR2 is required for GABBR1 maturation and transport to the plasma membrane. In contrast, GABBR2 does not depend on GABBR1 for transport to the cell membrane.</text>
</comment>
<comment type="tissue specificity">
<text evidence="12 13 14 25">Highly expressed in brain, especially in cerebral cortex, thalamus, hippocampus, frontal, occipital and temporal lobe, occipital pole and cerebellum, followed by corpus callosum, caudate nucleus, spinal cord, amygdala and medulla (PubMed:10087195, PubMed:10328880, PubMed:10727622, PubMed:9872744). Weakly expressed in heart, testis and skeletal muscle (PubMed:10087195, PubMed:10727622).</text>
</comment>
<comment type="domain">
<text evidence="33">Alpha-helical parts of the C-terminal intracellular region mediate heterodimeric interaction with GABBR1.</text>
</comment>
<comment type="disease" evidence="20 21 23">
<disease id="DI-05213">
<name>Neurodevelopmental disorder with poor language and loss of hand skills</name>
<acronym>NDPLHS</acronym>
<description>An autosomal dominant disorder characterized by psychomotor developmental stagnation or regression. NDPLHS manifest in the first years of life as loss of purposeful hand movements, loss of language, and intellectual disability.</description>
<dbReference type="MIM" id="617903"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="21 22 23">
<disease id="DI-05214">
<name>Epileptic encephalopathy, early infantile, 59</name>
<acronym>EIEE59</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. EIEE59 is an autosomal dominant condition characterized by onset of refractory seizures in early infancy.</description>
<dbReference type="MIM" id="617904"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="similarity">
<text evidence="32">Belongs to the G-protein coupled receptor 3 family. GABA-B receptor subfamily.</text>
</comment>
<comment type="sequence caution" evidence="32">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAH35071" version="2"/>
</conflict>
</comment>
<dbReference type="EMBL" id="AJ012188">
<property type="protein sequence ID" value="CAA09942.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF069755">
<property type="protein sequence ID" value="AAC99345.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF099033">
<property type="protein sequence ID" value="AAD45867.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF056085">
<property type="protein sequence ID" value="AAC63228.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF095784">
<property type="protein sequence ID" value="AAD30389.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF074483">
<property type="protein sequence ID" value="AAD03336.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL445495">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353782">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL356282">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AL591502">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC035071">
<property type="protein sequence ID" value="AAH35071.2"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS6736.1"/>
<dbReference type="RefSeq" id="NP_005449.5">
<property type="nucleotide sequence ID" value="NM_005458.7"/>
</dbReference>
<dbReference type="PDB" id="4F11">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.38"/>
<property type="chains" value="A=42-466"/>
</dbReference>
<dbReference type="PDB" id="4F12">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.02"/>
<property type="chains" value="A=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MQE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MQF">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.22"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MR7">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MR8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.15"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MR9">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MRM">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.86"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MS1">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.25"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MS3">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4MS4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="B=42-466"/>
</dbReference>
<dbReference type="PDB" id="4PAS">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.62"/>
<property type="chains" value="B=779-819"/>
</dbReference>
<dbReference type="PDB" id="6M8R">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.20"/>
<property type="chains" value="K/L=876-913"/>
</dbReference>
<dbReference type="PDB" id="6OCP">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.35"/>
<property type="chains" value="P/Q/R=895-909"/>
</dbReference>
<dbReference type="PDB" id="6UO8">
<property type="method" value="EM"/>
<property type="resolution" value="3.63"/>
<property type="chains" value="B=41-819"/>
</dbReference>
<dbReference type="PDB" id="6UO9">
<property type="method" value="EM"/>
<property type="resolution" value="4.80"/>
<property type="chains" value="B=41-819"/>
</dbReference>
<dbReference type="PDB" id="6UOA">
<property type="method" value="EM"/>
<property type="resolution" value="6.30"/>
<property type="chains" value="B=41-819"/>
</dbReference>
<dbReference type="PDB" id="6VJM">
<property type="method" value="EM"/>
<property type="resolution" value="3.97"/>
<property type="chains" value="B=41-819"/>
</dbReference>
<dbReference type="PDB" id="6W2X">
<property type="method" value="EM"/>
<property type="resolution" value="3.60"/>
<property type="chains" value="B=42-941"/>
</dbReference>
<dbReference type="PDB" id="6WIV">
<property type="method" value="EM"/>
<property type="resolution" value="3.30"/>
<property type="chains" value="B=1-819"/>
</dbReference>
<dbReference type="PDB" id="7C7Q">
<property type="method" value="EM"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="B=41-780"/>
</dbReference>
<dbReference type="PDB" id="7C7S">
<property type="method" value="EM"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="B=41-819"/>
</dbReference>
<dbReference type="PDBsum" id="4F11"/>
<dbReference type="PDBsum" id="4F12"/>
<dbReference type="PDBsum" id="4MQE"/>
<dbReference type="PDBsum" id="4MQF"/>
<dbReference type="PDBsum" id="4MR7"/>
<dbReference type="PDBsum" id="4MR8"/>
<dbReference type="PDBsum" id="4MR9"/>
<dbReference type="PDBsum" id="4MRM"/>
<dbReference type="PDBsum" id="4MS1"/>
<dbReference type="PDBsum" id="4MS3"/>
<dbReference type="PDBsum" id="4MS4"/>
<dbReference type="PDBsum" id="4PAS"/>
<dbReference type="PDBsum" id="6M8R"/>
<dbReference type="PDBsum" id="6OCP"/>
<dbReference type="PDBsum" id="6UO8"/>
<dbReference type="PDBsum" id="6UO9"/>
<dbReference type="PDBsum" id="6UOA"/>
<dbReference type="PDBsum" id="6VJM"/>
<dbReference type="PDBsum" id="6W2X"/>
<dbReference type="PDBsum" id="6WIV"/>
<dbReference type="PDBsum" id="7C7Q"/>
<dbReference type="PDBsum" id="7C7S"/>
<dbReference type="SMR" id="O75899"/>
<dbReference type="BioGRID" id="114938">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-2955">
<property type="entry name" value="GABA-B receptor complex"/>
</dbReference>
<dbReference type="CORUM" id="O75899"/>
<dbReference type="DIP" id="DIP-42851N"/>
<dbReference type="IntAct" id="O75899">
<property type="interactions" value="7"/>
</dbReference>
<dbReference type="MINT" id="O75899"/>
<dbReference type="STRING" id="9606.ENSP00000259455"/>
<dbReference type="BindingDB" id="O75899"/>
<dbReference type="ChEMBL" id="CHEMBL5034"/>
<dbReference type="DrugBank" id="DB08891">
<property type="generic name" value="Arbaclofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB08892">
<property type="generic name" value="Arbaclofen Placarbil"/>
</dbReference>
<dbReference type="DrugBank" id="DB00181">
<property type="generic name" value="Baclofen"/>
</dbReference>
<dbReference type="DrugBank" id="DB02530">
<property type="generic name" value="gamma-Aminobutyric acid"/>
</dbReference>
<dbReference type="DrugBank" id="DB05010">
<property type="generic name" value="SGS-742"/>
</dbReference>
<dbReference type="DrugCentral" id="O75899"/>
<dbReference type="GuidetoPHARMACOLOGY" id="241"/>
<dbReference type="TCDB" id="9.A.14.15.1">
<property type="family name" value="the g-protein-coupled receptor (gpcr) family"/>
</dbReference>
<dbReference type="GlyGen" id="O75899">
<property type="glycosylation" value="5 sites"/>
</dbReference>
<dbReference type="iPTMnet" id="O75899"/>
<dbReference type="PhosphoSitePlus" id="O75899"/>
<dbReference type="BioMuta" id="GABBR2"/>
<dbReference type="EPD" id="O75899"/>
<dbReference type="MassIVE" id="O75899"/>
<dbReference type="PaxDb" id="O75899"/>
<dbReference type="PeptideAtlas" id="O75899"/>
<dbReference type="PRIDE" id="O75899"/>
<dbReference type="ProteomicsDB" id="50252"/>
<dbReference type="ABCD" id="O75899">
<property type="antibodies" value="1 sequenced antibody"/>
</dbReference>
<dbReference type="Antibodypedia" id="2939">
<property type="antibodies" value="557 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="9568"/>
<dbReference type="Ensembl" id="ENST00000259455">
<property type="protein sequence ID" value="ENSP00000259455"/>
<property type="gene ID" value="ENSG00000136928"/>
</dbReference>
<dbReference type="GeneID" id="9568"/>
<dbReference type="KEGG" id="hsa:9568"/>
<dbReference type="UCSC" id="uc004ays.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="9568"/>
<dbReference type="DisGeNET" id="9568"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000136928.5"/>
<dbReference type="GeneCards" id="GABBR2"/>
<dbReference type="HGNC" id="HGNC:4507">
<property type="gene designation" value="GABBR2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000136928">
<property type="expression patterns" value="Tissue enriched (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="GABBR2"/>
<dbReference type="MIM" id="607340">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617903">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="617904">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_O75899"/>
<dbReference type="OpenTargets" id="ENSG00000136928"/>
<dbReference type="Orphanet" id="3095">
<property type="disease" value="Atypical Rett syndrome"/>
</dbReference>
<dbReference type="PharmGKB" id="PA28896"/>
<dbReference type="eggNOG" id="KOG1055">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000155783"/>
<dbReference type="HOGENOM" id="CLU_005240_0_0_1"/>
<dbReference type="InParanoid" id="O75899"/>
<dbReference type="KO" id="K04615"/>
<dbReference type="OMA" id="LLKHYHW"/>
<dbReference type="OrthoDB" id="590810at2759"/>
<dbReference type="PhylomeDB" id="O75899"/>
<dbReference type="TreeFam" id="TF313965"/>
<dbReference type="PathwayCommons" id="O75899"/>
<dbReference type="Reactome" id="R-HSA-1296041">
<property type="pathway name" value="Activation of G protein gated Potassium channels"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-418594">
<property type="pathway name" value="G alpha (i) signalling events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-420499">
<property type="pathway name" value="Class C/3 (Metabotropic glutamate/pheromone receptors)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-977444">
<property type="pathway name" value="GABA B receptor activation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-997272">
<property type="pathway name" value="Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits"/>
</dbReference>
<dbReference type="BioGRID-ORCS" id="9568">
<property type="hits" value="2 hits in 870 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="GABBR2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="GeneWiki" id="GABBR2"/>
<dbReference type="GenomeRNAi" id="9568"/>
<dbReference type="Pharos" id="O75899">
<property type="development level" value="Tclin"/>
</dbReference>
<dbReference type="PRO" id="PR:O75899"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 9"/>
</dbReference>
<dbReference type="RNAct" id="O75899">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000136928">
<property type="expression patterns" value="Expressed in primary visual cortex and 171 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="O75899">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="O75899">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038039">
<property type="term" value="C:G protein-coupled receptor heterodimeric complex"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902710">
<property type="term" value="C:GABA receptor complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0005887">
<property type="term" value="C:integral component of plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043005">
<property type="term" value="C:neuron projection"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045211">
<property type="term" value="C:postsynaptic membrane"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0004965">
<property type="term" value="F:G protein-coupled GABA receptor activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0046982">
<property type="term" value="F:protein heterodimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="CAFA"/>
</dbReference>
<dbReference type="GO" id="GO:0004888">
<property type="term" value="F:transmembrane signaling receptor activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0007268">
<property type="term" value="P:chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0007186">
<property type="term" value="P:G protein-coupled receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0007214">
<property type="term" value="P:gamma-aminobutyric acid signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007194">
<property type="term" value="P:negative regulation of adenylate cyclase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0150099">
<property type="term" value="P:neuron-glial cell signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="InterPro" id="IPR001828">
<property type="entry name" value="ANF_lig-bd_rcpt"/>
</dbReference>
<dbReference type="InterPro" id="IPR041689">
<property type="entry name" value="GBR2_CC"/>
</dbReference>
<dbReference type="InterPro" id="IPR002455">
<property type="entry name" value="GPCR3_GABA-B"/>
</dbReference>
<dbReference type="InterPro" id="IPR000337">
<property type="entry name" value="GPCR_3"/>
</dbReference>
<dbReference type="InterPro" id="IPR017978">
<property type="entry name" value="GPCR_3_C"/>
</dbReference>
<dbReference type="InterPro" id="IPR017979">
<property type="entry name" value="GPCR_3_CS"/>
</dbReference>
<dbReference type="InterPro" id="IPR002457">
<property type="entry name" value="GPCR_3_GABA_rcpt_B2"/>
</dbReference>
<dbReference type="InterPro" id="IPR028082">
<property type="entry name" value="Peripla_BP_I"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR10519">
<property type="entry name" value="PTHR10519"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00003">
<property type="entry name" value="7tm_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF01094">
<property type="entry name" value="ANF_receptor"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF18455">
<property type="entry name" value="GBR2_CC"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR01178">
<property type="entry name" value="GABAB2RECPTR"/>
</dbReference>
<dbReference type="PRINTS" id="PR00248">
<property type="entry name" value="GPCRMGR"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF53822">
<property type="entry name" value="SSF53822"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00981">
<property type="entry name" value="G_PROTEIN_RECEP_F3_3"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50259">
<property type="entry name" value="G_PROTEIN_RECEP_F3_4"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-1015">Disulfide bond</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0297">G-protein coupled receptor</keyword>
<keyword id="KW-0325">Glycoprotein</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-0628">Postsynaptic cell membrane</keyword>
<keyword id="KW-0675">Receptor</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0807">Transducer</keyword>
<keyword id="KW-0812">Transmembrane</keyword>
<keyword id="KW-1133">Transmembrane helix</keyword>
<feature type="signal peptide" evidence="10">
<location>
<begin position="1"/>
<end position="41"/>
</location>
</feature>
<feature type="chain" description="Gamma-aminobutyric acid type B receptor subunit 2" id="PRO_0000012952">
<location>
<begin position="42"/>
<end position="941"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="42"/>
<end position="483"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=1" evidence="10">
<location>
<begin position="484"/>
<end position="504"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="505"/>
<end position="522"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=2" evidence="10">
<location>
<begin position="523"/>
<end position="543"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="544"/>
<end position="551"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=3" evidence="10">
<location>
<begin position="552"/>
<end position="572"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="573"/>
<end position="597"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=4" evidence="10">
<location>
<begin position="598"/>
<end position="618"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="619"/>
<end position="654"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=5" evidence="10">
<location>
<begin position="655"/>
<end position="675"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="676"/>
<end position="691"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=6" evidence="10">
<location>
<begin position="692"/>
<end position="712"/>
</location>
</feature>
<feature type="topological domain" description="Extracellular" evidence="10">
<location>
<begin position="713"/>
<end position="720"/>
</location>
</feature>
<feature type="transmembrane region" description="Helical; Name=7" evidence="10">
<location>
<begin position="721"/>
<end position="741"/>
</location>
</feature>
<feature type="topological domain" description="Cytoplasmic" evidence="10">
<location>
<begin position="742"/>
<end position="941"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="10">
<location>
<begin position="781"/>
<end position="819"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="776"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="779"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine" evidence="8">
<location>
<position position="819"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="884"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="893"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="913"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="916"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="920"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="8">
<location>
<position position="924"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="90"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="10">
<location>
<position position="298"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="389"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18 19">
<location>
<position position="404"/>
</location>
</feature>
<feature type="glycosylation site" description="N-linked (GlcNAc...) asparagine" evidence="18">
<location>
<position position="453"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="108"/>
<end position="135"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="237"/>
<end position="266"/>
</location>
</feature>
<feature type="disulfide bond">
<location>
<begin position="265"/>
<end position="302"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs35449008." id="VAR_049280">
<original>L</original>
<variation>P</variation>
<location>
<position position="163"/>
</location>
</feature>
<feature type="sequence variant" description="In NDPLHS; increased basal signaling activity and only weak stimulation by GABA agonist; when injected into Xenopus tadpoles, causes abnormal swimming patterns and increased frequencies of seizure-like behavior compared to wild-type-injected animals; no effect on cell surface expression; dbSNP:rs922847767." id="VAR_079029" evidence="20 21 23">
<original>A</original>
<variation>T</variation>
<location>
<position position="567"/>
</location>
</feature>
<feature type="sequence variant" id="VAR_010148" evidence="13">
<original>Y</original>
<variation>F</variation>
<location>
<position position="628"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE59; unknown pathological significance; dbSNP:rs1554689320." id="VAR_080569" evidence="22">
<original>G</original>
<variation>W</variation>
<location>
<position position="693"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE59; full signaling activity in the absence of GABA agonist; when injected into Xenopus tadpoles, causes abnormal swimming patterns and increased frequencies of seizure-like behavior compared to wild-type-injected animals; no effect on cell surface expression; dbSNP:rs1554689319." id="VAR_080570" evidence="21 23">
<original>S</original>
<variation>I</variation>
<location>
<position position="695"/>
</location>
</feature>
<feature type="sequence variant" description="In EIEE59; increased basal signaling activity and no stimulation by GABA agonist; when injected into Xenopus tadpoles, causes abnormal swimming patterns and increased frequencies of seizure-like behavior compared to wild-type-injected animals; no effect on cell surface expression; dbSNP:rs1554689315." id="VAR_080571" evidence="21 23">
<original>I</original>
<variation>N</variation>
<location>
<position position="705"/>
</location>
</feature>
<feature type="sequence variant" description="In NDPLHS; increased basal signaling activity and only weak stimulation by GABA agonist; no effect on cell surface expression; dbSNP:rs1554689313." id="VAR_080572" evidence="23">
<original>A</original>
<variation>T</variation>
<location>
<position position="707"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs10985765." id="VAR_010149" evidence="13">
<original>T</original>
<variation>A</variation>
<location>
<position position="869"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs interaction with GABBR1. Decreases signaling via G-proteins." evidence="18">
<original>Y</original>
<variation>A</variation>
<location>
<position position="118"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC99345." ref="2" evidence="32">
<original>S</original>
<variation>R</variation>
<location>
<position position="6"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 2; AAC99345." ref="2" evidence="32">
<original>P</original>
<variation>R</variation>
<location>
<position position="12"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; AAD30389." ref="5" evidence="32">
<original>G</original>
<variation>E</variation>
<location>
<position position="424"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 8; AAH35071." ref="8" evidence="32">
<original>R</original>
<variation>H</variation>
<location>
<position position="797"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="55"/>
<end position="62"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="66"/>
<end position="68"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="71"/>
<end position="90"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="91"/>
<end position="96"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="98"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="110"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="128"/>
<end position="132"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="136"/>
<end position="145"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="146"/>
<end position="149"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="152"/>
<end position="157"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="161"/>
<end position="164"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="166"/>
<end position="168"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="172"/>
<end position="176"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="179"/>
<end position="181"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="182"/>
<end position="192"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="197"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="206"/>
<end position="219"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="220"/>
<end position="223"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="225"/>
<end position="234"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="237"/>
<end position="245"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="250"/>
<end position="254"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="257"/>
<end position="269"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="278"/>
<end position="283"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="287"/>
<end position="290"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="304"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="315"/>
<end position="319"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="335"/>
<end position="345"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="346"/>
<end position="348"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="355"/>
<end position="372"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="378"/>
<end position="387"/>
</location>
</feature>
<feature type="helix" evidence="3">
<location>
<begin position="393"/>
<end position="404"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="407"/>
<end position="410"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="413"/>
<end position="418"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="421"/>
<end position="423"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="425"/>
<end position="431"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="436"/>
<end position="443"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="444"/>
<end position="447"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="448"/>
<end position="451"/>
</location>
</feature>
<feature type="turn" evidence="3">
<location>
<begin position="453"/>
<end position="455"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="459"/>
<end position="462"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="780"/>
<end position="816"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="885"/>
<end position="890"/>
</location>
</feature>
<feature type="helix" evidence="6">
<location>
<begin position="899"/>
<end position="902"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="908"/>
<end position="911"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MQE"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MR7"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4MS4"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4PAS"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6M8R"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6OCP"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="O88871"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q80T41"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q9Z0U4"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000255"/>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10075644"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10087195"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10328880"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10727622"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10773016"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15617512"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18165688"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22660477"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24305054"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26740508"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28856709"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29100083"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29369404"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9872316"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9872744"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10087195"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10328880"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10727622"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="9872316"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000303">
<source ref="6"/>
</evidence>
<evidence key="32" type="ECO:0000305"/>
<evidence key="33" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="9872744"/>
</source>
</evidence>
<sequence length="941" mass="105821" checksum="09F1773DB0673C5D" modified="1998-11-01" version="1" precursor="true">MASPRSSGQPGPPPPPPPPPARLLLLLLLPLLLPLAPGAWGWARGAPRPPPSSPPLSIMGLMPLTKEVAKGSIGRGVLPAVELAIEQIRNESLLRPYFLDLRLYDTECDNAKGLKAFYDAIKYGPNHLMVFGGVCPSVTSIIAESLQGWNLVQLSFAATTPVLADKKKYPYFFRTVPSDNAVNPAILKLLKHYQWKRVGTLTQDVQRFSEVRNDLTGVLYGEDIEISDTESFSNDPCTSVKKLKGNDVRIILGQFDQNMAAKVFCCAYEENMYGSKYQWIIPGWYEPSWWEQVHTEANSSRCLRKNLLAAMEGYIGVDFEPLSSKQIKTISGKTPQQYEREYNNKRSGVGPSKFHGYAYDGIWVIAKTLQRAMETLHASSRHQRIQDFNYTDHTLGRIILNAMNETNFFGVTGQVVFRNGERMGTIKFTQFQDSREVKVGEYNAVADTLEIINDTIRFQGSEPPKDKTIILEQLRKISLPLYSILSALTILGMIMASAFLFFNIKNRNQKLIKMSSPYMNNLIILGGMLSYASIFLFGLDGSFVSEKTFETLCTVRTWILTVGYTTAFGAMFAKTWRVHAIFKNVKMKKKIIKDQKLLVIVGGMLLIDLCILICWQAVDPLRRTVEKYSMEPDPAGRDISIRPLLEHCENTHMTIWLGIVYAYKGLLMLFGCFLAWETRNVSIPALNDSKYIGMSVYNVGIMCIIGAAVSFLTRDQPNVQFCIVALVIIFCSTITLCLVFVPKLITLRTNPDAATQNRRFQFTQNQKKEDSKTSTSVTSVNQASTSRLEGLQSENHRLRMKITELDKDLEEVTMQLQDTPEKTTYIKQNHYQELNDILNLGNFTESTDGGKAILKNHLDQNPQLQWNTTEPSRTCKDPIEDINSPEHIQRRLSLQLPILHHAYLPSIGGVDASCVSPCVSPTASPRHRHVPPSFRVMVSGL</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

